약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
Table. 2. Formula according to mixing of EC, pectin, Eudragit® RSPO and RLPO into HPMC K100M on sustained release part in dual-release matrix tablet containing sarpogrelate HCl
Composition Formulation (%, W/W)
F10 F11 F12 F13 F14 F15 F16 F17 F18 F19 F20
SGH 57.05 57.05 57.05 57.05 57.05 57.05 57.05 57.05 57.05 57.05 57.05
CA 2.54 2.54 2.54 2.54 2.54 2.54 2.54 2.54 2.54 2.54 2.54
PVP K30 2.38 2.38 2.38 2.38 2.38 2.38 2.38 2.38 2.38 2.38 2.38
Avicel® 101 26.15 26.15 26.15 2.38 2.38 2.38 2.38 2.38 2.38 2.38 2.38
HPMC K100M 8.88 5.95 3.01 28.53 23.77 28.53 23.77 28.53 23.77 28.53 23.77
EC 3.01 5.95 8.88 7.13 11.89 - - - - - -
Pectin - - - - - 7.13 11.89
Eudragit® RLPO - - - - - - - 7.13 11.89 - -
Eudragit® RS O P - - - - - - - - - 7.13 11.89
Flowability Fair Fair Passable Excellent Good Passable Passable Good Good Good Good
Bulk density (kg/m3) 0.45 0.46 0.45 0.46 0.48 0.46 0.47 0.44 0.47 0.44 0.48
Tap density (kg/m3) 0.55 0.55 0.57 0.50 0.56 0.59 0.59 0.49 0.53 0.49 0.54
Hausner’s ratio 1.21 1.20 1.26 1.09 1.17 1.28 1.26 1.11 1.13 1.11 1.13
Carr’s Index 17.27 16.51 20.91 8.00 14.29 22.03 20.34 10.20 11.32 10.20 11.11
Weight variation (mg) 510.21±1.03 512.25±1.27 511.24±5.56 509.21±2.02 506.34±1.07 510.6±1.27 510.40±0.57 508.87±3.13 512.33±1.08 511.07±3.13 513.80±3.21
Content (%) 98.27±1.34 98.45±3.02 98.77±1.22 98.59±0.92 99.06±0.71 100.67±0.42 98.84±0.34 98.63±0.31 98.73±0.32 99.27±2.98 101.23±2.48
Friability (%) 0.20 0.21 0.19 0.18 0.16 0.17 0.24 0.18 0.22 0.15 0.16
Hardness (kgf) 5.7 5.7 5.7 6.3 6.6 5.8 6.9 6.2 5.8 6.4 6.1
Yakhak Hoeji 2024;68:252-68 https://doi.org/10.17480/psk.2024.68.4.252
© 2024 Yakhak Hoeji